Msh Capital Advisors LLC Zoetis Inc. Transaction History

Msh Capital Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$162.24 - $194.42 $207,018 - $248,079	-1,276 Closed	0 $0
Q2 2024 Feb 13, 2025	BUY	$145.54 - $178.83 $172,028 - $211,377	1,182 New	1,182 $205 Million
Q1 2024 Feb 13, 2025	SELL	$165.67 - $199.94 $181,242 - $218,734	-1,094 Closed	0 $0
Q4 2023 Feb 13, 2025	SELL	$151.44 - $200.09 $17,869 - $23,610	-118 Reduced 9.74%	1,094 $216 Million
Q3 2023 Feb 13, 2025	BUY	$167.14 - $192.77 $1,504 - $1,734	9 Added 0.75%	1,212 $211 Million
Q2 2023 Feb 13, 2025	BUY	$160.94 - $186.23 $193,610 - $224,034	1,203 New	1,203 $207 Million
Q2 2022 Feb 13, 2025	SELL	$155.97 - $200.09 $6,238 - $8,003	-40 Reduced 3.04%	1,276 $219 Million
Q1 2022 Feb 13, 2025	BUY	$181.39 - $234.03 $4,534 - $5,850	25 Added 1.94%	1,316 $248 Million
Q4 2021 Feb 13, 2025	BUY	$193.69 - $247.03 $250,053 - $318,915	1,291 New	1,291 $315 Million

2,031

416M

1.23M

1.3M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $73.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Msh Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Msh Capital Advisors LLC with notifications on news.